METFORMIN AND DICHOLOROACETATE COMBINATION EXERT A SYNERGISTIC EFFECT ON CELL VIABILITY OF ORAL SQUAMOUS CELL CARCINOMA

Objective: To assess the effects of Metformin, Dichloroacetate  (DCA) and their combination on cell viability in oral squamous  cell carcinoma, UPCI-SCC-131 cell line. Methods: UPCI-SCC-131 cells were plated in 96 E-plate (1x104  cells/well) and were treated with Metformin (1-16mM) and/or  DCA (15-120mM) for 24-48-72h. xCELLigence SP system was used  to monitor real time cell viability. In addition, drug combination  index was analyzed with CompuSyn software according to  Chou-Talalay method. Results: Half-maximal inhibitory concentrations (IC50) of Metformin  and DCA were found to be 3mM and 23mM, respectively,  for 72 hours. CI values (0.76-0.80) in all combination groups below  1 indicated that Metformin/DCA combination had a moderate  synergistic effect on cell viability in UPCI-SCC-131 cells. Discussion: Metformin/DCA combination synergistically decreased  the cell viability of UPCI-SCC-131 cells. Therefore, a combined  application of Metformin and DCA may be considered as  a candidate therapy for the “drug repositioning” of the treatment  of oral cavity cancer.

• Publication year

  2019

• Venue

  ENT Updates

• Publication date

  2019-08-08

• Fields of study

  Medicine

• Identifiers
  DOI 10.32448/ENTUPDATES.569464
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of dichloroacetate as single agent or in combination with GW6471 and metformin in paraganglioma cells

  2018cited by this paper
• Hallmarks of Cancer-Related Newly Prognostic Factors of Oral Squamous Cell Carcinoma

  2018cited by this paper
• Reversal of the Warburg effect with DCA in PDGF-treated human PASMC is potentiated by pyruvate dehydrogenase kinase-1 inhibition mediated through blocking Akt/GSK-3β signalling

  2018cited by this paper
• Treatment of Pancreatic Cancer Patient–Derived Xenograft Panel with Metabolic Inhibitors Reveals Efficacy of Phenformin

  2017cited by this paper
• Metformin in combination with 5-fluorouracil suppresses tumor growth by inhibiting the Warburg effect in human oral squamous cell carcinoma.

  2016cited by this paper
• Metformin inhibits prostate cancer cell proliferation, migration, and tumor growth through upregulation of PEDF expression

  2016cited by this paper
• Dichloroacetate and metformin synergistically suppress the growth of ovarian cancer cells

  2016cited by this paper
• Metformin increases PDH and suppresses HIF-1α under hypoxic conditions and induces cell death in oral squamous cell carcinoma

  2016influential reference
• Metformin sensitizes the response of oral squamous cell carcinoma to cisplatin treatment through inhibition of NF-κB/HIF-1α signal axis

  2016cited by this paper
• Targeting HIF-1α is a prerequisite for cell sensitivity to dichloroacetate (DCA) and metformin.

  2016cited by this paper
• Erratum: Metformin sensitizes the response of oral squamous cell carcinoma to cisplatin treatment through inhibition of NF-κB/HIF-1α signal axis

  2016cited by this paper
• The prognostic value of metformin for cancer patients with concurrent diabetes: a systematic review and meta‐analysis

  2014cited by this paper
• Dichloroacetate enhances apoptotic cell death via oxidative damage and attenuates lactate production in metformin-treated breast cancer cells

  2014cited by this paper
• Sensitization of metformin-cytotoxicity by dichloroacetate via reprogramming glucose metabolism in cancer cells.

  2014cited by this paper
• Metformin potentiates the effects of paclitaxel in endometrial cancer cells through inhibition of cell proliferation and modulation of the mTOR pathway.

  2012cited by this paper
• Oral Squamous Cell Carcinoma: Epidemiology, Clinical Presentation and Treatment

  2012cited by this paper
• Metformin Induces Both Caspase-Dependent and Poly(ADP-ribose) Polymerase-Dependent Cell Death in Breast Cancer Cells

  2011cited by this paper
• Metformin decreases the dose of chemotherapy for prolonging tumor remission in mouse xenografts involving multiple cancer cell types.

  2011cited by this paper
• Oxygen Consumption Can Regulate the Growth of Tumors, a New Perspective on the Warburg Effect

  2009cited by this paper
• Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors.

  1984influential reference

• The mechanisms of action of metformin on head and neck cancer in the pre-clinical setting: a scoping review

  2024cites this paper
• Cancer cachexia has many symptoms but only one cause: anoxia

  2020cites this paper